The Valley Desk

NCT02565186 · Interventional trial

An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine

Overall registry status Completed

Phase 3

Conditions Migraine Disorders

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov